Altered subcellular distribution of transcriptional regulators in response to Aβ peptide and during Alzheimer's disease

Mechanisms of Ageing and Development

Volumn 123, Issue 1, 2001, Pages 11-20

  Jordan Sciutto, K ^a   Rhodes, J ^a   Bowser, R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Cell cycle; E2F1; Retinoblastoma protein; Transcription factor

Indexed keywords

AMYLOID BETA PROTEIN; CELL CYCLE PROTEIN; GENE PRODUCT; PROTEIN FAC1; SERINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL CELL; BRAIN TISSUE; CELL STRAIN; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEURITE; NEUROTOXICITY; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIGENS, NUCLEAR; BRAIN; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; HUMANS; MIDDLE AGED; NERVE TISSUE PROTEINS; PC12 CELLS; PEPTIDE FRAGMENTS; PEPTIDES; PHOSPHORYLATION; RATS; RETINOBLASTOMA PROTEIN; SUBCELLULAR FRACTIONS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0034793625     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(01)00334-7     Document Type: Conference Paper

References (38)

1. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease
2. Aberrancies in signal transduction and cell cycle related events in Alzheimer's disease
3. Aging, energy, and oxidative stress in neurodegenerative diseases
4. Vitamin E protects nerve cells from amyloid β protein toxicity
5. FAC1, a novel gene identified with the monoclonal antibody Alz50, is developmentally regulated in human brain
6. Expression of FAC1 in activated microglia during Alzheimer's disease
7. Analysis of cell cycle-related gene expression in postmitotic neurons: Selective induction of cyclin D1 during programmed cell death
8. E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3
9. Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F-DP, in B-amyloid-induced neuronal death
10. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor
11. The induction of multiple cell cycle events precedes target-related neuronal death
12. Possible causes of Alzheimer's disease: Amyloid fragments, free radicals, and calcium homeostasis
13. Effects of an Rb mutation in the mouse
14. Oxidative stress and the pathogenesis of Parkinson's disease
15. Inductive signals and the assignment of cell fate in the spinal cord and hindbrain
16. Alzheimer's disease and brain development: Common molecular mechanisms
17. Fetal Alz-50 clone 1 (FAC1) protein interacts with the myc associated zinc finger protein (ZF87/MAZ) and alters its transcriptional activity
18. Fetal Alz-50 clone 1, a novel zinc-finger protein, binds a specific DNA sequence and acts as a transcriptional regulator
19. Transcription factor NF-kB is activated in primary neurons by amyloid B peptides and in neurons surrounding early plaques from patients with Alzheimer's disease
20. Inhibition of NF-kB potentiates amyloid b-mediated neuronal apoptosis
21. Changes of p53 in the brains of patients with Alzheimer's disease
22. Alteration of transcription factors NF-kB and STAT1 in Alzheimer's disease brains
23. Cyclin D1 is an essential mediator of apoptotic neuronal cell death
24. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
25. Expression of Fos, Jun, and Krox family proteins in Alzheimer's disease
26. Mechanisms of cell death in Alzheimer disease-immunopathology
27. Re-entry into the cell cycle: A mechanism for neurodegeneration in Alzheimer disease
28. Signal transduction abnormalities in Alzheimer's disease: Evidence of a pathogenic stimuli
29. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). II. Standardization of the neuropathological assessment of Alzheimer's disease
30. The role of cell cycle-mediated events in Alzheimer's disease
31. Cell division and the nervous system: Regulating the cycle from neural differentiation to death
32. Immunolocalization and redistribution of the FAC1 protein in Alzheimer's disease
33. Transcription factors in early development of the central nervous system
34. Glutamate, excitotoxicity and amyotrophic lateral sclerosis
35. Induction of mitosis-related genes during dopamine-triggered apoptosis in sympathetic neurons
36. Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type
37. Nerve growth factor potentiates the neurotoxicity of B amyloid
38. Identification and analysis of the complete cDNA sequence for the human FAC1 gene